Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination
NCT02485912
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Ebola Virus Disease
Interventions
BIOLOGICAL:
ChAd3-EBO Z
BIOLOGICAL:
MVA-EBO Z
Sponsor
University of Oxford
Collaborators
[object Object]